Massmutual Trust CO Fsb Biogen Inc. Transaction History

Massmutual Trust CO Fsb

  • $3.28 Billion
  • Q2 2024

A detailed history of Massmutual Trust CO Fsb transactions in Biogen Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 494 shares of BIIB stock, worth $110,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
494
Previous 333 48.35%
Holding current value
$110,957
Previous $71,000 60.56%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024
BUY
$190.52 - $236.72 $30,673 - $38,111
161 Added 48.35%
494 $114,000
Q1 2024

Apr 09, 2024
BUY
$212.02 - $267.71 $19,505 - $24,629
92 Added 38.17%
333 $71,000
Q4 2023

Jan 03, 2024
BUY
$222.59 - $267.94 $2,225 - $2,679
10 Added 4.33%
241 $62,000
Q3 2023

Oct 03, 2023
SELL
$253.3 - $285.89 $5,825 - $6,575
-23 Reduced 9.06%
231 $59,000
Q2 2023

Aug 01, 2023
BUY
$275.25 - $318.06 $14,863 - $17,175
54 Added 27.0%
254 $72,000
Q1 2023

Apr 11, 2023
BUY
$256.56 - $292.34 $21,551 - $24,556
84 Added 72.41%
200 $55,000
Q4 2022

Jan 06, 2023
BUY
$252.44 - $306.72 $2,019 - $2,453
8 Added 7.41%
116 $32,000
Q3 2022

Oct 07, 2022
BUY
$194.69 - $268.46 $4,672 - $6,443
24 Added 28.57%
108 $29,000
Q2 2022

Jul 07, 2022
BUY
$187.54 - $223.02 $2,062 - $2,453
11 Added 15.07%
84 $17,000
Q1 2022

Apr 08, 2022
BUY
$193.77 - $244.14 $10,657 - $13,427
55 Added 305.56%
73 $15,000
Q4 2021

Feb 09, 2022
SELL
$223.92 - $287.77 $7,165 - $9,208
-32 Reduced 64.0%
18 $4,000
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $3.11 Million - $4.06 Million
-10,998 Reduced 99.55%
50 $14,000
Q2 2021

Aug 16, 2021
SELL
$259.0 - $414.71 $58,793 - $94,139
-227 Reduced 2.01%
11,048 $3.83 Million
Q1 2021

May 17, 2021
BUY
$242.95 - $284.63 $62,195 - $72,865
256 Added 2.32%
11,275 $3.15 Million
Q4 2020

Feb 16, 2021
SELL
$236.26 - $355.63 $213,106 - $320,778
-902 Reduced 7.57%
11,019 $2.7 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $41,568 - $47,996
-157 Reduced 1.3%
11,921 $3.38 Million
Q2 2020

Aug 13, 2020
BUY
$258.66 - $342.55 $130,105 - $172,302
503 Added 4.35%
12,078 $3.23 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $29,304 - $37,173
-109 Reduced 0.93%
11,575 $3.66 Million
Q4 2019

May 15, 2020
SELL
$220.06 - $304.07 $17,164 - $23,717
-78 Reduced 0.66%
11,684 $3.47 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $179,605 - $201,444
-826 Reduced 6.56%
11,762 $2.74 Million
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $326,084 - $359,437
-1,487 Reduced 10.56%
12,588 $2.94 Million
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $63,062 - $98,637
291 Added 2.11%
14,075 $3.33 Billion
Q4 2018

Feb 26, 2019
BUY
$278.5 - $352.75 $40,104 - $50,796
144 Added 1.06%
13,784 $4.15 Billion
Q3 2018

Nov 09, 2018
SELL
$293.51 - $383.83 $349,570 - $457,141
-1,191 Reduced 8.03%
13,640 $4.82 Billion
Q2 2018

Aug 20, 2018
BUY
$257.52 - $306.91 $360,528 - $429,674
1,400 Added 10.42%
14,831 $4.3 Billion
Q1 2018

May 21, 2018
BUY
$260.13 - $367.91 $188,854 - $267,102
726 Added 5.71%
13,431 $3.68 Billion
Q4 2017

Mar 01, 2018
SELL
$307.64 - $344.58 $16.8 Million - $18.8 Million
-54,540 Reduced 81.11%
12,705 $4.05 Billion
Q4 2017

Feb 21, 2018
BUY
$307.64 - $344.58 $17.3 Million - $19.3 Million
56,114 Added 504.12%
67,245 $4.31 Billion
Q3 2017

Feb 13, 2018
BUY
$281.15 - $329.69 $53,980 - $63,300
192 Added 1.76%
11,131 $3.49 Billion
Q2 2017

Aug 14, 2017
BUY
N/A
10,939
10,939 $2.97 Billion

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email